SOFRAMYCIN SKIN
Manufacturer Details
SANOFI AVENTIS
SANOFI INDIA LTD
SANOFI HOUSE, CTS NO 117-B
L&T BUSINESS PARK
SAKI VIHAR ROAD, POWAI
ANDHERI EAST, MUMBAI 400072
Compositions:
Soframmycin sulp 1%+Methy paraben 0.08%+Propyl paraben 0.04 all w/w cream,
|
Strength
|
Rate
|
Packing Style
|
|
1%+0.08%+0.04%
|
41.61
|
30g cream
|
|
1%+0.08%+0.04%
|
130.48
|
100g cream
|
List of Related Indications:
List Of Drugs:
- Framycetin - (Soframycin) - (FDC- List )(Apr 1987)
Indication Type Description:
Drug Interaction:
Reports not available
Indication:
Skin infections Ottitis extrena Furunculosis Burns and scalds
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
1.Framycetin Sulphate 1% + April 1987
Hydrocortisone Acetate 1% +
Miconazole Nitrate 2%
2. Framycetin sulphate 1%+ 28-10-1993
Dexamethasone 0.1% +
Clotrimazole 1% cream
In the treatment of dermatologic disoreders caused by
complicated infections by bacteria and/or fungi along
with inflammation
Adverse Reaction:
Reports not available
Contra-Indications:
Viral and tubercular lesions Vaicella vaccina Special precautions: Allergy to streptomyces derived antibiotics If large areas of skin are being treated ear toxicity may be a hazard,particularly in children, in the eldely and in patients with renal impairment
Dosages/ Overdosage Etc:
Skin infections Ottitis extrena Furunculosis Burns and scalds
Dosage-
Apply 1-3 times daily
Other Information:
Classification: Antibiotic Patent position: Major brands: SOFRAMYCIN ROUSSEL MARKET LEADER Ceilin price Price/Rs Notification Framycetin sulphate 14470/kg 2(E) Jan 1,1997 Domestic production 93/94 4.77T Demand projection 94/95 5T
